Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors

J. K. Hicks, J. R. Bishop, K. Sangkuhl, D. J. Muller, Y. Ji, S. G. Leckband, J. S. Leeder, R. L. Graham, D. L. Chiulli, A. LLerena, T. C. Skaar, S. A. Scott, J. C. Stingl, T. E. Klein, K. E. Caudle, A. Gaedigk

Research output: Contribution to journalArticlepeer-review

762 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience